Robert Deem
Family Medicine · Monticello, FLNPI 1619972387
Payments from drug & device makers
Across 262 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$703
- Boehringer Ingelheim$631
- Lilly USA, LLC$485
- Novo Nordisk$339
- Pfizer$332
- Merck$310
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,28699%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $703 |
| Boehringer Ingelheim | 32 | $631 |
| Lilly USA, LLC | 31 | $485 |
| Novo Nordisk | 18 | $339 |
| Pfizer | 22 | $332 |
| Merck | 20 | $310 |
| Johnson & Johnson | 13 | $217 |
| Amarin Pharma, Inc. | 14 | $182 |
| Sanofi Pasteur Inc. | 11 | $169 |
| GSK | 8 | $131 |
| Kowa Pharmaceuticals America, Inc. | 7 | $108 |
| Amgen | 7 | $107 |
| Exact Sciences | 5 | $98 |
| AbbVie | 7 | $96 |
| Novartis | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 2 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Bayer | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Smith+Nephew | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$4,324 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 179 | $213,976 |
| JardianceEmpagliflozin | 79 | $113,196 |
| JanuviaSitagliptin Phosphate | 93 | $96,629 |
| MounjaroTirzepatide | 55 | $77,000 |
| EntrestoSacubitril/Valsartan | 38 | $74,266 |
| TrulicityDulaglutide | 34 | $62,685 |
| OzempicSemaglutide | 36 | $48,298 |
| FarxigaDapagliflozin Propanediol | 46 | $44,847 |
| JanumetSitagliptin Phos/Metformin Hcl | 43 | $37,787 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 31 | $34,724 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $27,695 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $24,445 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 14 | $23,820 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $23,674 |
| TradjentaLinagliptin | 16 | $22,090 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $332 | $213,976179 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Glyxambi | $631 | $180,912133 claims |
| MerckJanuvia, Janumet, Janumet Xr | $310 | $169,141167 claims |
| Lilly USA, LLCMounjaro, Trulicity | $485 | $139,68589 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $703 | $98,256119 claims |
| NovartisEntresto | $67 | $74,26638 claims |
| Novo NordiskOzempic | $339 | $48,29836 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $131 | $34,96847 claims |
| AbbVieLinzess | $96 | $13,04012 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $17 | $4,138323 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $23 | $3,90843 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Monticello
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.